References
- Acloque, H., Adams, M.S., Fishwick, K., Bronner-Fraser, M., and Nieto, M.A. (2009). Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J. Clin. Invest. 119, 1438-1449. https://doi.org/10.1172/JCI38019
- Ahn, H.M., Yoo, J.W., Lee, S., Lee, H.J., Lee, H.S., and Lee, D.S. (2017). Peroxiredoxin 5 promotes the epithelial-mesenchymal transition in colon cancer. Biochem. Biophys. Res. Commun. 487, 580-586. https://doi.org/10.1016/j.bbrc.2017.04.094
- Alahari, S.K., Schmidt, H., and Kaufer, N.F. (1993). The fission yeast prp4+ gene involved in pre-mRNA splicing codes for a predicted serine/threonine kinase and is essential for growth. Nucleic Acids Res. 21, 4079-4083. https://doi.org/10.1093/nar/21.17.4079
- Arumugam, T., Ramachandran, V., Fournier, K.F., Wang, H., Marquis, L., Abbruzzese, J.L., Gallick, G.E., Logsdon, C.D., McConkey, D.J., and Choi, W. (2009). Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res. 69, 5820-5828. https://doi.org/10.1158/0008-5472.CAN-08-2819
- Bauer, J.A., Ye, F., Marshall, C.B., Lehmann, B.D., Pendleton, C.S., Shyr, Y., Arteaga, C.L., and Pietenpol, J.A. (2010). RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells. Breast Cancer Res. 12, R41. https://doi.org/10.1186/bcr2595
-
Bian, Q., Liu, P., Gu, J., and Song, B. (2015). Tubeimoside-1 inhibits the growth and invasion of colorectal cancer cells through the Wnt/
${\beta}$ -catenin signaling pathway. Int. J. Clin. Exp. Pathol. 8, 12517. - Du, B. and Shim, J. (2016). Targeting epithelial-mesenchymal transition (EMT) to overcome drug resistance in cancer. Molecules 21, 965. https://doi.org/10.3390/molecules21070965
- Duan, Z., Weinstein, E.J., Ji, D., Ames, R.Y., Choy, E., Mankin, H., and Hornicek, F.J. (2008). Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer. Mol. Cancer Ther. 7, 2377-2385. https://doi.org/10.1158/1535-7163.MCT-08-0316
- Fischer, K.R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S.T., Choi, H., El Rayes, T., Ryu, S., and Troeger, J. (2015). Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 527, 472. https://doi.org/10.1038/nature15748
- Gao, Q., Mechin, I., Kothari, N., Guo, Z., Deng, G., Haas, K., McManus, J., Hoffmann, D., Wang, A., Wiederschain, D., et al. (2013). Evaluation of cancer dependence and druggability of PRP4 kinase using cellular, biochemical, and structural approaches. J. Biol. Chem. 288, 30125-30138. https://doi.org/10.1074/jbc.M113.473348
- Giroux, V., Iovanna, J., and Dagorn, J.C. (2006). Probing the human kinome for kinases involved in pancreatic cancer cell survival and gemcitabine resistance. FASEB J. 20, 1982-1991. https://doi.org/10.1096/fj.06-6239com
- Haynes, C. and Iakoucheva, L.M. (2006). Serine/arginine-rich splicing factors belong to a class of intrinsically disordered proteins. Nucleic Acids Res. 34, 305-312. https://doi.org/10.1093/nar/gkj424
- Huang, J., Li, H., and Ren, G. (2015). Epithelial-mesenchymal transition and drug resistance in breast cancer. Int. J. Oncol. 47, 840-848. https://doi.org/10.3892/ijo.2015.3084
- Islam, S.U., Ahmed, M.B., Lee, S.J., Shehzad, A., Sonn, J.K., Kwon, O.S., and Lee, Y.S. (2018). PRP4 kinase induces actin rearrangement and epithelialmesenchymal transition through modulation of the actin-binding protein cofilin. Exp. Cell Res. 369, 158-165. https://doi.org/10.1016/j.yexcr.2018.05.018
- Islam, S.U., Shehzad, A., and Lee, Y.S. (2015). Prostaglandin E2 inhibits resveratrol-induced apoptosis through activation of survival signaling pathways in HCT-15 cell lines. Anim. Cells Syst. (Seoul) 19, 374-384. https://doi.org/10.1080/19768354.2015.1101398
- Islam, S.U., Shehzad, A., Sonn, J.K., and Lee, Y.S. (2017). PRPF overexpression induces drug resistance through actin cytoskeleton rearrangement and epithelial-mesenchymal transition. Oncotarget 8, 56659. https://doi.org/10.18632/oncotarget.17855
- Kojima, T., Zama, T., Wada, K., Onogi, H., and Hagiwara, M. (2001). Cloning of human PRP4 reveals interaction with Clk1. J. Biol. Chem. 276, 32247-32256. https://doi.org/10.1074/jbc.M103790200
- Lamouille, S., Xu, J., and Derynck, R. (2014). Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178. https://doi.org/10.1038/nrm3758
- Lee, S., Lee, J.S., Seo, J., Lee, S.H., Kang, J.H., Song, J., and Kim, S.Y. (2018). Targeting mitochondrial oxidative phosphorylation abrogated irinotecan resistance in NSCLC. Sci. Rep. 8, 15707. https://doi.org/10.1038/s41598-018-33667-6
- Lutzelberger, M. and Kaufer, N.F. (2012). The Prp4 kinase: its substrates, function and regulation in pre-mRNA splicing. In Protein Phosphorylation in Human Health, C. Huang, ed. (London, UK: IntechOpen), Chapter 6.
- McConkey, D.J., Choi, W., Marquis, L., Martin, F., Williams, M.B., Shah, J., Svatek, R., Das, A., Adam, L., and Kamat, A. (2009). Role of epithelialto-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev. 28, 335-344. https://doi.org/10.1007/s10555-009-9194-7
- Micalizzi, D.S., Farabaugh, S.M., and Ford, H.L. (2010). Epithelialmesenchymal transition in cancer: parallels between normal development and tumor progression. J. Mammary Gland Biol. Neoplasia 15, 117-134. https://doi.org/10.1007/s10911-010-9178-9
- Michels, J., Kepp, O., Senovilla, L., Lissa, D., Castedo, M., Kroemer, G., and Galluzzi, L. (2013). Functions of BCL-X L at the interface between cell death and metabolism. Int. J. Cell Biol. 2013, 705294. https://doi.org/10.1155/2013/705294
- Rosenberg, G.H., Alahari, S.K., and Kaufer, N.F. (1991). prp4 from Schizosaccharomyces pombe, a mutant deficient in pre-mRNA splicing isolated using genes containing artificial introns. Mol. Gen. Genet. 226, 305-309. https://doi.org/10.1007/BF00273617
- Shehzad, A., Islam, S.U., Ahn, E.M., Lee, Y.M., and Lee, Y.S. (2016). Decursinol angelate inhibits PGE2-induced survival of the human leukemia HL-60 cell line via regulation of the EP2 receptor and NFkappaB pathway. Cancer Biol. Ther. 17, 985-993. https://doi.org/10.1080/15384047.2016.1210740
- Shehzad, A., Lee, J., Huh, T.L., and Lee, Y.S. (2013). Curcumin induces apoptosis in human colorectal carcinoma (HCT-15) cells by regulating expression of Prp4 and p53. Mol. Cells 35, 526-532. https://doi.org/10.1007/s10059-013-0038-5
- Sommers, C.L., Heckford, S.E., Skerker, J.M., Worland, P., Torri, J.A., Thompson, E.W., Byers, S.W., and Gelmann, E.P. (1992). Loss of epithelial markers and acquisition of vimentin expression in adriamycin-and vinblastine-resistant human breast cancer cell lines. Cancer Res. 52, 5190-5197.
- Van Roy, F. and Berx, G. (2008). The cell-cell adhesion molecule E-cadherin. Cell. Mol. Life Sci. 65, 3756-3788. https://doi.org/10.1007/s00018-008-8281-1
- Wlodkowic, D., Skommer, J., and Darzynkiewicz, Z. (2009). Flow cytometrybased apoptosis detection. Methods Mol. Biol. 559, 19-32. https://doi.org/10.1007/978-1-60327-017-5_2
- Zheng, X., Carstens, J.L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.C., LeBleu, V.S., and Kalluri, R. (2015). Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 527, 525-530. https://doi.org/10.1038/nature16064
Cited by
- Herbal NF-κB Inhibitors Sensitize Rituximab-Resistant B Lymphoma Cells to Complement-Mediated Cytolysis vol.11, 2020, https://doi.org/10.3389/fonc.2021.751904
- Endoplasmic Reticulum Stress Induces CAP2 Expression Promoting Epithelial-Mesenchymal Transition in Liver Cancer Cells vol.44, pp.8, 2020, https://doi.org/10.14348/molcells.2021.0031